Arrayit Corporation
524 East Weddell Drive
Sunnyvale, CA 94089
USA
Phone 408-744-1331
FAX 408-744-1711
Email arrayit@arrayit.com
Web www.arrayit.com
Twitter www.twitter.com/arrayit
 

Corporate Newsletter
Click here to sign up for the Arrayit newsletter.

Recent News
11/14/12 Arrayit Diagnostics Files S-1 Registration Statement.
10/4/12 Arrayit Diagnostics, Inc. Announces $8 Million Financing Commitment.
4/17/12 Arrayit Corporation Posts 60% Quarterly Sales Increase.
4/4/12 Arrayit Diagnostics, Inc. Reports Results of Research Study for Ovarian Cancer Diagnostic Test.
3/21/12 Arrayit Spokesperson Khrystyne Haje to Appear on Rachael Ray to Support Cancer Patients in Treatment.
2/15/12 Arrayit Corporation Announces Stock Dividend Distribution Date for Shareholders.

Learn, Explore and Discover

More News
2/2/12 Arrayit's CEO, Rene Schena, Chosen to Promote Economic Growth Center to Big Pharma and Biotech Businesses.
12/14/11 Arrayit Corporation to Spin-Off Arrayit Diagnostics, Inc. to Shareholders.
8/3/11 Arrayit Corporation Reports 47% Revenue Growth.
4/1/11 Arrayit Corporation Announces the Product Launch of OvaDx®, the Market's First Pre-Symptomatic Screening Test for Ovarian Cancer.
9/20/11 Arrayit Corporation Completes Proteomics Platform Installation and Training at the National Institutes of Health.
8/23/10 Arrayit Corporation Announces Premarket Approval (PMA) Submission Strategy for OvaDx®.
8/15/10 Arrayit Corporation Adds 128 New Products to Its Life Sciences Tools Portfolio.
6/16/10 Arrayit Corporation Technology May Provide Vital Clues to Detoxification of the Oceans.
5/10/10 Arrayit Corporation Reports Strong Surge in Customer Demand for the Company's Leading Edge Life Sciences Microarray Instruments.